Role of some Immunological and non-Immunological Parameters in Prognosis and diagnosis of Systemic lupus erythematosus in Iraqi women patients
DOI:
https://doi.org/10.23851/mjs.v34i4.1363Keywords:
autoimmune disease, Systemic lupus erythematosus, IL17, IFN-γ, TLR7, ANA, anti-dsDNAAbstract
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by autoantibody's presence in the circulation and involvement of many systems. The current study aims to study the role of some immunological and non-immunological parameters in SLE development and to illustrate the correlations between these parameters. The current study included 50 blood samples collected from SLE patients and apparently healthy control. The methods of work included Complete Blood Count (CBC) analysis to assess blood components, you mean to analyse Hb, WBC, ESR, ELISA technique to measure serum levels of TLR-7, IL-17, and TNF-γ, antinuclear antibody test (ANA) and double-strand DNA antibody (anti ds DNA). The study results showed a significant increase in serum levels of each WBC (p< 0.005), ESR (p< 0.001), IL17(p< 0.004), TLR7(p< 0.005), IFN-γ (p< 0.001), ANA (p< 0.001), and anti dsDNA (p< 0.001) in SLE patients compared to apparently healthy control but the Hb is decreasing level was low in the SLE patients compared with control. In conclusion, the low hemoglobin, WBC, and ESR are non-specific parameters associated with SLE pathogenesis. ANA, Anti-ds-DNA as excellent biomarkers for the diagnosis of SLE and serum level of TLR-7, TNF-γ, and IL-17 were evaluated in SLE patients compared to healthy people and they may be suggested as a prognostic tool in SLE patients.
Received: 03/04/2023
Revised: 13/06/2023
Accepted: 08/07/2023
Downloads
References
S. Molina Rios, R. Rojas Martinez GM Estévez Ramirez, YF Medina. Systemic Lupus Erythematosus and Antiphospholipid Syndrome After COVID-19 Vaccination. A Case Report. Mod Rheumatol Case Rep. 2022 Mar 04
MG. Tayem, L. Shahin, J. Shook, MM Kesselman. A Review of Cardiac Manifestations in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome With a Focus on Endocarditis. Cureus. 2022 Jan;14(1):e21698.
M. Scheen, A. Adedjouma, E. Esteve, D. Buob, N. Abisror, V. Planche, O. Fain, JJ Boffa S. De Seigneux, A. Mekinian, F. Haidar. Kidney disease in antiphospholipid antibody syndrome: Risk factors, pathophysiology and management. Autoimmun Rev. 2022 May;21(5):103072.
D. L. Su, Z. M. Lu, M.N. Shen, X. Li, & L.Y. Sun, Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. Journal of biomedicine & biotechnology, 2012, 347141.
N. Amatya, AV. Garg, SL. Gaffen . IL-17 Signaling: The Yin and the Yang. Trends Immunol.May;38(5):310-322. 2017.
T. Koga, K. Ichinose, A. Kawakami, GC Tsokos. Current Insights and Future Prospects for Targeting IL-17 to Treat Patients with Systemic Lupus Erythematosus. Front Immunol.Feb1;11:624971. 2021.
J.C. Martin,. D. L. Baeten,. R. Josien,. Emerging role of IL-17 and Th17 cells in systemic lupus erythematosus, Clinical Immunology,Volume 154, Issue 1,2014,Pages 1-12, 2014
JC. Santacruz, MJ. Mantilla,I. Rueda ,S Pulido,G. Rodriguez-Salas, J. Londono. A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus. Cureus. 2022 Mar 7;14(3):e22938.
A. Paradowska-Gorycka, A. Wajda, B Stypinska, E. Walczuk, E. Rzeszotarska, M Walczyk, et al. Variety of endosomal TLRs and interferons (IFN-a, IFN-b, IFNg) expression profiles in patients with SLE, SSc and MCTD. Clin Exp Immunol 2021 204:49-63.
S. Mohammadi, S. Sedighi, A. Memarian, &Y. Yazdani. Overexpression of interferon-γ and indoleamine 2, 3-dioxygenase in systemic lupus erythematosus: relationship with the disease activity. Laboratoriums Medizin,41(1), 41-47. 2017
V. Oke, I. Gunnarsson, J. Dorschner et al. High levels of circulating interferons type I, type II and type III associate with distinct clinical features of active systemic lupus erythematosus. Arthritis Res Ther 2019;21:107
W. Liu, , S. Zhang, &J. Wang,. IFN-γ, should not be ignored in SLE. Frontiers in Immunology, 13, 954706. 2022
J. Yang,Y. Chu, X. Yang, D. Gao, L. Zhu X. Yang, et al. Th17 and natural treg cell population dynamics in systemic lupus erythematosus. Arthritis Rheum 60:1472-83. 2009.
D. Zhao, M. Guo, B. Liu et al . Frontline science. Tim-3-mediated dysfunctional engulfment of apoptotic cells in SLE. J Leukoc Biol, 102: 1313-22 23 . 2017
T. Schmidt, H-J. Paust, CF. Krebs, J-E. Turner, A. Kaffke, SB. Bennstein, et al. Function of the Th17/interleukin-17A immune response in murine lupus nephritis. Arthritis Rheumatol, 67:475-87. 2015.
T. Koga ,K. Otomo, M. Mizui, N. Yoshida M. Umeda, K. Ichinose, et al. Calcium/Calmodulin-dependent kinase IV facilitates the recruitment of interleukin-17-Producing cells to target organs through the CCR6/CCL20 axis in Th17 cell-driven inflammatory diseases. Arthritis Rheumatol , 68:1981-8. 2016.
CK. Wong, LC. Lit, LS. Tam, EK. Li, PT. Wong, CW. Lam. Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin Immunol; 127: 385-393.2008.
XF. Zhao, HF. Pan, H. Yuan, et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep; 37: 81-85 2010
T. Wang, J. Marken, J. Chen, V. B.Tran, Q. Z. Li, ,M. Li, & N. V Giltiay. High TLR7 expression drives the expansion of CD19+ CD24hiCD38hi transitional B cells and autoantibody production in SLE patients. Frontiers in immunology, 10, 1243, 2019.â€
M. Santiago-Raber,.I. Dunand-Sauthier, T Wu,. Q Li,. S. Uematsu, S. Akira, W. Reith, C Mohan, B.L. Kotzin, S. Izui,. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice, Journal of Autoimmunity; 34 (4): 339-348.2010.
B. D. Lyn-Cook, C. Xie, J Oates., E. Treadwell, B. Word, G Hammons, & K. Wiley, Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Molecular immunology, 61(1), 38-43. 2014
Q. Ge,. X. Gu,. W. Yu,. G. Zhang, W. Liang,.M. Li, G. Zhai, M. Yan. Antinuclear antibodies in healthy population: Positive association with abnormal tissue metabolism, inflammation and immune dysfunction. International Immunopharmacology, Volume 113, Part A,2022,109292.
D. A. González, Varela, A. R Varela, I. M RodrÃguez , A.G. Vera, M.D. Sánchez,. A.A. Esquivel, C.C. RodrÃguez, A. C. de León, Anti-dsDNA antibodies in systemic lupus erythematosus: A combination of two quantitative methods and the ANA pattern is the most efficient strategy of detection, Journal of Immunological Methods,Volume 427,2015,Pages 30-35.
AS. Wiik, N. Bizzaro. Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases. It is all about the patient! Autoimmun Highlights.; 3:35-49. 2010
J. Gołąb, M. Jakóbisiak,W. Lasek, et al. Immunologia. Warszawa: PWN; 2014.
B. Grygiel-Górniak, N. Rogacka, & M Puszczewicz, Antinuclear antibodies in healthy people and non-rheumatic diseases - diagnostic and clinical implications. Reumatologia, 56(4), 243-248.2018. https://doi.org/10.5114/reum.2018.77976
Downloads
Key Dates
Published
Issue
Section
License
Copyright (c) 2023 Al-Mustansiriyah Journal of Science
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Articles accepted for publication in Al-Mustansiriyah Journal of Science (MJS) are protected under the Creative Commons Attribution 4.0 International License (CC BY-NC). Authors of accepted articles are requested to sign a copyright release form prior to their article being published. All authors must agree to the submission, sign copyright release forms, and agree to be included in any correspondence between MJS and the authors before submitting a work to MJS. For personal or educational use, permission is given without charge to print or create digital copies of all or portions of a MJS article. However, copies must not be produced or distributed for monetary gain. It is necessary to respect the copyright of any parts of this work that are not owned by MJS.
How to Cite
